WHO technical advisory group to discuss Covaxin EUL on October 26
Hyderabad: The technical advisory group of the World Health Organisation (WHO) will meet on October 26 to consider emergency use listing for Bharat Biotech's COVID-19 vaccine Covaxin, tweeted Soumya Swaminathan, chief scientist of the global health body, on Sunday.
"The technical advisory group will meet on Oct 26th to consider EUL for #Covaxin. @WHO has been working closely with @BharatBiotech to complete the dossier. Our goal is to have a broad portfolio of vaccines approved for emergency use & to expand access to populations everywhere," she tweeted.
The Strategic Advisory Group of Experts on Immunization (SAGE) of the WHO which held a meeting on October 6 to make its recommendations on Covaxin on EUL, among other issues, had earlier said it will take a call on granting EUL status to Covaxin in a week time.
The EUL process being carried out by the WHO and the Technical Advisory Group of independent experts - is centered on determining if a manufactured product such as vaccine is quality-assured, safe and effective, WHO earlier said.
"The WHO is currently reviewing the data submitted by the vaccine maker and the date for a decision on the jab is "October 2021" according to the update available on the WHO website," reports PTI.
The indigenous, inactivated vaccine is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
